Propanc Biopharma, Inc. (PPCB) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-14.85 | +99.0% |
| 2024 | $-1420.53 | -78818.3% |
| 2023 | $-1.80 | +96.3% |
| 2022 | $-49.23 | -6053.7% |
| 2021 | $-0.80 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-14.85 | +99.0% |
| 2024 | $-1420.53 | -78818.3% |
| 2023 | $-1.80 | +96.3% |
| 2022 | $-49.23 | -6053.7% |
| 2021 | $-0.80 | — |